Oncogenes in thyroid cancer (Q35217001)

7 August 2017

1 reference

title

Oncogenes in thyroid cancer (English)

1 reference

7 August 2017

Kim DS

1 reference

7 August 2017

McCabe CJ

series ordinal

1 reference

7 August 2017

Buchanan MA

series ordinal

1 reference

7 August 2017

Watkinson JC

series ordinal

1 reference

7 August 2017

publication date

1 October 2003

1 reference

7 August 2017

published in

Clinical Otolaryngology

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

386-395

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

7 August 2017

1 reference

Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Mutations of mitotic checkpoint genes in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

The Ras pathway and spindle assembly collide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Isolation and characterization of a pituitary tumor-transforming gene (PTTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Securin is required for chromosomal stability in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Immune responses to DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

Expression of pituitary-tumour transforming gene in colorectal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2003.00732.X

10.1046/J.1365-2273.2003.00732.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference